Results 181 to 190 of about 38,593 (257)

Role of aldosterone in various target organ damage in patients with hypertensive emergency: a cross-sectional study. [PDF]

open access: yesBMC Nephrol
Miyake A   +13 more
europepmc   +1 more source

Comparative Efficacy and Safety of Antihypertensive Strategies in Diabetic Kidney Disease: Protocol for an Update of a Systematic Review and Component Network Meta‐Analysis

open access: yesHealth Science Reports, Volume 9, Issue 8, August 2026.
ABSTRACT Background and Aims Chronic kidney disease (CKD) is a significant global contributor to morbidity and mortality, with hypertension and diabetes mellitus remaining its primary causes. Effective antihypertensive treatment is a key modifiable strategy to improve outcomes in this population. However, the emergence of novel therapies, together with
Jamie J. Edwards   +16 more
wiley   +1 more source

The FemTech revolution: Unlocking the potential of new technology for optimizing pregnancy outcomes in low‐ and middle‐income countries and remote areas

open access: yesInternational Journal of Gynecology &Obstetrics, Volume 174, Issue 2, Page 530-553, August 2026.
Abstract Maternal and neonatal mortality and morbidity rates uncover major global health disparities. Despite ongoing efforts, the rates of maternal and neonatal complications remain substantially higher in low‐ and middle‐income countries (LMICs) compared to high‐income countries (HICs). These high rates are the result of several unmet needs in LMICs,
Nir Melamed   +19 more
wiley   +1 more source

The Therapeutic Potential of H2S‐Releasing Platforms in Cardiovascular Applications

open access: yesJournal of Biomedical Materials Research Part B: Applied Biomaterials, Volume 114, Issue 8, August 2026.
The Therapeutic Potential of H2S‐Releasing Platforms. ABSTRACT Once known as a toxic gas, hydrogen sulfide (H2S) is now making its way into many therapeutic applications. Similar to its other fellow endogenous gasotransmitters, nitric oxide and carbon monoxide, H2S is a small gas with a short half‐life, making it extremely capable of penetrating ...
Tia N. Shorter, Elizabeth J. Brisbois
wiley   +1 more source

Myocardial Lipid Metabolism Imbalance: The Pathological Core and Novel Diagnostic‐Therapeutic Directions of Cardiovascular Diseases

open access: yesJournal of Biochemical and Molecular Toxicology, Volume 40, Issue 8, August 2026.
In cardiac cells, Plin5/AMPK regulate lipid homeostasis; excess CD36‐mediated uptake drives lipotoxicity, mitochondrial dysfunction, and CVDs (e.g., heart failure). Biomarkers (ApoB/ApoA‐1) and therapies (SGLT2 inhibitors) target this cascade. ABSTRACT Cardiac lipid metabolism is fundamental to myocardial energy homeostasis, with fatty acid oxidation ...
Peiyun Xie   +3 more
wiley   +1 more source

Predictors and Outcomes of 30‐Day Readmissions Following Electrical Cardioversion for Atrial Fibrillation: Insights From the Nationwide Readmissions Database

open access: yesJournal of Arrhythmia, Volume 42, Issue 4, August 2026.
Among 134 114 atrial fibrillation hospitalizations treated with electrical cardioversion in the 2016–2017 NRD, 9.9% resulted in 30‐day readmission. Readmission was associated with higher mortality, longer stay and greater costs. Predictors included cardiometabolic comorbidities, female sex, lower income, Medicare/Medicaid insurance, nonhome discharge ...
Adeena Jamil   +12 more
wiley   +1 more source

Cardio‐Protective Effect of GLP‐1 Agonists in OSA Patients: A Study of Cardiovascular Risk

open access: yesLaryngoscope Investigative Otolaryngology, Volume 11, Issue 4, August 2026.
ABSTRACT Objective Obstructive sleep apnea (OSA) is highly associated with obesity and often results in significant cardiovascular complications. This study aimed to assess cardiovascular outcomes in OSA patients treated with GLP‐1 agonists (GLP1a) versus CPAP.
Morgan Lane   +6 more
wiley   +1 more source

Risk Factors for Cardiovascular Disease: Epidemiology, Screening, Prevention, and Therapeutic Interventions

open access: yesMedComm, Volume 7, Issue 8, August 2026.
Cardiovascular disease arises from lifelong accumulation of traditional and emerging risk factors that converge on shared pathophysiological pathways, leading to diverse clinical outcomes, and can be mitigated through integrated screening, prevention, and precision therapies. ABSTRACT Cardiovascular diseases (CVDs) remain the leading cause of morbidity
Mowei Kong   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy